Novartis Wins Temporary Stay on Heart Failure Drug's Generic Version in US
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.29 CHF | -0.43% |
|
+4.17% | +10.16% |
Feb. 06 | AlphaValue/Baader Europe: Novartis Shares 'Hold More Value' After Strong FY24 | MT |
Feb. 06 | NOVARTIS AG : Goldman Sachs gives a Neutral rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration